Simcere Pharmaceutical IPO Initiation: A Rough Patch?
The timing of the IPO is not ideal as Simcere is coming off a weak 1H20. However, Simcere is putting in place the right measures to ensure that the...
390 Views
HSCI Index Rebalance - Stock Connect Flows Coming Up
The Hang Seng Indexes Company Limited (HSIL) announced the results of its review of the Hang Seng Family of Indexes post market close on 14 August....
488 Views
HSCI and Stock Connect - Biotech Stocks Now Eligible; Inclusion & Exclusion Possibilities
Hang Seng Indexes Company (HSIL) reviews the constituents of the Hang Seng Composite Index (HSCI) on a half yearly basis in March and September...
769 Views
Alphamab Lock-Up Expiry: Promising Clinical Data Since IPO, Worth a Reverse Inquiry
Alphamab's lock-up expiry for cornerstone investors will come on June 12th, 2020. Upon lock-up expiry USD 686 million worth of stake held by...
380 Views
Kintor Pharma IPO Initiation: To Screen, or Not to Screen?
Kintor Pharmaceutical (1762178D CH) is a clinical-stage drug developer with a focus on potential first-in-class and best-in-class drugs for cancers...
280 Views